Introduction: Endocrine-disrupting chemicals (EDCs) mimic or antagonize the actions of hormones, thus they exert potentially adverse health effects on organisms. Most EDCs act on nuclear receptors, particularly sex hormone receptors, including the estrogen receptor (ER) a/b, androgen receptor (AR), and progesterone receptor (PR). Materials and Methods: To validate our recently developed yeast-based reporter gene assays for human sex steroid hormone receptors in the detection of EDCs, we performed agonist and antagonist assays with 30 test compounds, including endogenous and synthetic hormones, antagonist pharmaceuticals, and known EDCs. Results: Our yeast-based assays were highly sensitive and robust: the half activation concentration (AC 50 ) values of endogenous sex hormones were in the ranges of low picomolar for ERs, picomolar to low nanomolar for AR, and low nanomolar for PR, in the current experimental condition. Receptor-selective agonist and antagonist activities of known EDCs were detected with reliable sensitivity, and the differences in EDC activity between structurally related compounds were distinguishable. Furthermore, we found receptor selectivity that was not previously reported for some EDCs. Discussion and Conclusions: We showed that EDCs were qualitatively and quantitatively detectable in yeast. The sensitive yeast-based assays that can be carried out using easy and cost-effective procedures are advantageous and valuable to detect as yet unidentified EDCs binding to sex hormone receptors. The yeast-based assay system is considered to be one of the primary screening tools of EDCs in the field of novel agrochemical development and assessment of environmental pollutants.